Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complex Partial Seizure Disorder”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Large-scale testing (Phase 3)Study completedNCT00319501
What this trial is testing

Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

Who this might be right for
SeizuresEpilepsies, PartialEpilepsy, Complex Partial+2 more
Pfizer 234
Early research (Phase 1)Study completedNCT03156439
What this trial is testing

Bioavailability, Safety, and Tolerability of BIS-001 ER

Who this might be right for
Epilepsy, Complex Partial
Supernus Pharmaceuticals, Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01002820
What this trial is testing

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Who this might be right for
Epilepsy, Complex Partial
Marinus Pharmaceuticals 11
Large-scale testing (Phase 3)Ended earlyNCT02519439
What this trial is testing

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 26
Large-scale testing (Phase 3)Ended earlyNCT00310388
What this trial is testing

Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097

Who this might be right for
Epilepsy
GlaxoSmithKline 376
Post-approval studies (Phase 4)Study completedNCT00537940
What this trial is testing

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Who this might be right for
EpilepsyPartial Seizure DisorderEpilepsies, Partial+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 482
Not applicableLooking for participantsNCT07012148
What this trial is testing

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

Who this might be right for
Focal EpilepsyGeneralized SeizureDrug Refractory Epilepsy
Mayo Clinic 12
Large-scale testing (Phase 3)Study completedNCT00292461
What this trial is testing

Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Who this might be right for
Epilepsy
Eisai Inc. 64
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Not applicableEnded earlyNCT00013845
What this trial is testing

Evaluation and Treatment of Patients With Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 1,278
Not applicableStudy completedNCT01073579
What this trial is testing

Sabril Patient Registry

Who this might be right for
Infantile SpasmsRefractory Complex Partial Seizures in Adults
Lundbeck LLC 9,423
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Large-scale testing (Phase 3)Study completedNCT00232596
What this trial is testing

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 306
Large-scale testing (Phase 3)Study completedNCT01749046
What this trial is testing

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Who this might be right for
EpilepsySimple Partial SeizuresComplex Partial Seizures+1 more
Valexfarm 224
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT00143143
What this trial is testing

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Who this might be right for
Epilepsies, PartialEpilepsy, Complex Partial
Pfizer 300
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Large-scale testing (Phase 3)Study completedNCT01713946
What this trial is testing

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Who this might be right for
Tuberous Sclerosis Complex-associated Refractory Seizures
Novartis Pharmaceuticals 366
Load More Results